KR102513929B1 - Functional comsmetics materials having composition and composition ratio for skin elasticity, Manufacturing method thereof and Comsmetics for skin care - Google Patents
Functional comsmetics materials having composition and composition ratio for skin elasticity, Manufacturing method thereof and Comsmetics for skin care Download PDFInfo
- Publication number
- KR102513929B1 KR102513929B1 KR1020220130769A KR20220130769A KR102513929B1 KR 102513929 B1 KR102513929 B1 KR 102513929B1 KR 1020220130769 A KR1020220130769 A KR 1020220130769A KR 20220130769 A KR20220130769 A KR 20220130769A KR 102513929 B1 KR102513929 B1 KR 102513929B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- parts
- extract
- skin
- phase
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 13
- 230000037394 skin elasticity Effects 0.000 title claims description 26
- 239000000203 mixture Substances 0.000 title claims description 25
- 239000000463 material Substances 0.000 title abstract 2
- 239000002537 cosmetic Substances 0.000 claims abstract description 69
- 239000000284 extract Substances 0.000 claims description 140
- 239000000243 solution Substances 0.000 claims description 58
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 47
- 239000003795 chemical substances by application Substances 0.000 claims description 32
- 230000037384 skin absorption Effects 0.000 claims description 30
- 231100000274 skin absorption Toxicity 0.000 claims description 30
- 239000007864 aqueous solution Substances 0.000 claims description 26
- 238000003756 stirring Methods 0.000 claims description 25
- 239000000839 emulsion Substances 0.000 claims description 24
- 239000004475 Arginine Substances 0.000 claims description 23
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 23
- 239000003995 emulsifying agent Substances 0.000 claims description 23
- 239000003381 stabilizer Substances 0.000 claims description 21
- 239000004909 Moisturizer Substances 0.000 claims description 20
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 20
- 230000001333 moisturizer Effects 0.000 claims description 20
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 18
- 241000196324 Embryophyta Species 0.000 claims description 18
- 229920002125 Sokalan® Polymers 0.000 claims description 18
- 239000003655 absorption accelerator Substances 0.000 claims description 18
- 229960001631 carbomer Drugs 0.000 claims description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 14
- 230000003750 conditioning effect Effects 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 14
- 238000002156 mixing Methods 0.000 claims description 14
- 239000008213 purified water Substances 0.000 claims description 12
- 239000004094 surface-active agent Substances 0.000 claims description 12
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 11
- 239000003755 preservative agent Substances 0.000 claims description 11
- 239000000375 suspending agent Substances 0.000 claims description 11
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 claims description 11
- 229960000401 tranexamic acid Drugs 0.000 claims description 11
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 10
- 229960000458 allantoin Drugs 0.000 claims description 10
- 239000003205 fragrance Substances 0.000 claims description 10
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 10
- 240000004385 Centaurea cyanus Species 0.000 claims description 9
- 235000005940 Centaurea cyanus Nutrition 0.000 claims description 9
- 235000013399 edible fruits Nutrition 0.000 claims description 9
- 238000010438 heat treatment Methods 0.000 claims description 9
- 239000003002 pH adjusting agent Substances 0.000 claims description 9
- 239000003352 sequestering agent Substances 0.000 claims description 9
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 8
- 230000036560 skin regeneration Effects 0.000 claims description 8
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 claims description 7
- 244000178870 Lavandula angustifolia Species 0.000 claims description 7
- 235000010663 Lavandula angustifolia Nutrition 0.000 claims description 7
- 244000042664 Matricaria chamomilla Species 0.000 claims description 7
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims description 7
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 claims description 7
- 235000011187 glycerol Nutrition 0.000 claims description 7
- 239000001102 lavandula vera Substances 0.000 claims description 7
- 235000018219 lavender Nutrition 0.000 claims description 7
- 229940100460 peg-100 stearate Drugs 0.000 claims description 7
- 230000002335 preservative effect Effects 0.000 claims description 7
- 230000008569 process Effects 0.000 claims description 7
- 229960005078 sorbitan sesquioleate Drugs 0.000 claims description 7
- 229950011392 sorbitan stearate Drugs 0.000 claims description 7
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 6
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 claims description 6
- 229940081733 cetearyl alcohol Drugs 0.000 claims description 6
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims description 6
- GJQLBGWSDGMZKM-UHFFFAOYSA-N ethylhexyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CC)CCCCC GJQLBGWSDGMZKM-UHFFFAOYSA-N 0.000 claims description 6
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 claims description 6
- 229940098324 green tea leaf extract Drugs 0.000 claims description 6
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 claims description 6
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 claims description 6
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 6
- 229940092258 rosemary extract Drugs 0.000 claims description 6
- 235000020748 rosemary extract Nutrition 0.000 claims description 6
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 claims description 6
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 6
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 5
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 5
- 229940008099 dimethicone Drugs 0.000 claims description 5
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 5
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 5
- 229940075529 glyceryl stearate Drugs 0.000 claims description 5
- 239000006166 lysate Substances 0.000 claims description 5
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 5
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 claims description 5
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 claims description 5
- 229940113124 polysorbate 60 Drugs 0.000 claims description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 4
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 claims description 4
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 4
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 claims description 4
- 240000004355 Borago officinalis Species 0.000 claims description 4
- 235000007689 Borago officinalis Nutrition 0.000 claims description 4
- 241000208467 Macadamia Species 0.000 claims description 4
- 244000234609 Portulaca oleracea Species 0.000 claims description 4
- 235000001855 Portulaca oleracea Nutrition 0.000 claims description 4
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 claims description 4
- 229960003964 deoxycholic acid Drugs 0.000 claims description 4
- 229940100524 ethylhexylglycerin Drugs 0.000 claims description 4
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 4
- 235000019136 lipoic acid Nutrition 0.000 claims description 4
- 229960002663 thioctic acid Drugs 0.000 claims description 4
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 claims description 3
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 claims description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 3
- 235000001405 Artemisia annua Nutrition 0.000 claims description 3
- 240000000011 Artemisia annua Species 0.000 claims description 3
- 235000005637 Brassica campestris Nutrition 0.000 claims description 3
- 241001301148 Brassica rapa subsp. oleifera Species 0.000 claims description 3
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 claims description 3
- 241000951471 Citrus junos Species 0.000 claims description 3
- 241000555678 Citrus unshiu Species 0.000 claims description 3
- 241001632578 Hyacinthus orientalis Species 0.000 claims description 3
- 240000007232 Illicium verum Species 0.000 claims description 3
- 235000008227 Illicium verum Nutrition 0.000 claims description 3
- WYQVAPGDARQUBT-FGWHUCSPSA-N Madecassol Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(CC[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O WYQVAPGDARQUBT-FGWHUCSPSA-N 0.000 claims description 3
- 241000691199 Taraxacum platycarpum Species 0.000 claims description 3
- 241000908178 Tremella fuciformis Species 0.000 claims description 3
- 241000051616 Ulmus minor Species 0.000 claims description 3
- WYQVAPGDARQUBT-XCWYDTOWSA-N asiaticoside Natural products O=C(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@H](O)[C@H](O)[C@H](O[C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)[C@@H](CO)O2)O1)[C@@]12[C@@H]([C@@H](C)[C@H](C)CC1)C=1[C@](C)([C@@]3(C)[C@@H]([C@@]4(C)[C@H]([C@@](CO)(C)[C@@H](O)[C@H](O)C4)CC3)CC=1)CC2 WYQVAPGDARQUBT-XCWYDTOWSA-N 0.000 claims description 3
- 229940022757 asiaticoside Drugs 0.000 claims description 3
- QCYLIQBVLZBPNK-UHFFFAOYSA-N asiaticoside A Natural products O1C(C(=O)C(C)C)=CC(C)C(C2(C(OC(C)=O)CC34C5)C)C1CC2(C)C3CCC(C1(C)C)C45CCC1OC1OCC(O)C(O)C1O QCYLIQBVLZBPNK-UHFFFAOYSA-N 0.000 claims description 3
- 229940119162 calendula officinalis flower extract Drugs 0.000 claims description 3
- 229960004203 carnitine Drugs 0.000 claims description 3
- 229940043350 citral Drugs 0.000 claims description 3
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 claims description 3
- 229930007744 linalool Natural products 0.000 claims description 3
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 claims description 3
- 241000208473 Macadamia ternifolia Species 0.000 claims description 2
- 241001072909 Salvia Species 0.000 claims 2
- 235000017276 Salvia Nutrition 0.000 claims 2
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 claims 1
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 abstract description 5
- 230000002500 effect on skin Effects 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 96
- 230000000052 comparative effect Effects 0.000 description 16
- 230000000694 effects Effects 0.000 description 14
- 230000002087 whitening effect Effects 0.000 description 12
- 239000004615 ingredient Substances 0.000 description 10
- 230000003020 moisturizing effect Effects 0.000 description 10
- 239000006071 cream Substances 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 8
- 239000000469 ethanolic extract Substances 0.000 description 7
- 230000006872 improvement Effects 0.000 description 7
- 244000182022 Salvia sclarea Species 0.000 description 6
- 235000002911 Salvia sclarea Nutrition 0.000 description 6
- 210000002615 epidermis Anatomy 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 5
- 240000004307 Citrus medica Species 0.000 description 5
- 241000675108 Citrus tangerina Species 0.000 description 5
- 241001632576 Hyacinthus Species 0.000 description 5
- 229940045955 star anise extract Drugs 0.000 description 5
- 240000001432 Calendula officinalis Species 0.000 description 4
- 235000005881 Calendula officinalis Nutrition 0.000 description 4
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 4
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 4
- 235000017945 Matricaria Nutrition 0.000 description 4
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 241000245665 Taraxacum Species 0.000 description 4
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 4
- 229940107605 borage extract Drugs 0.000 description 4
- 210000004207 dermis Anatomy 0.000 description 4
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 229940064064 purslane extract Drugs 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 230000001172 regenerating effect Effects 0.000 description 4
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 3
- 239000004264 Petrolatum Substances 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 241001106462 Ulmus Species 0.000 description 3
- 229940124532 absorption promoter Drugs 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 238000007872 degassing Methods 0.000 description 3
- 239000003906 humectant Substances 0.000 description 3
- 239000002085 irritant Substances 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 239000002075 main ingredient Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 231100000344 non-irritating Toxicity 0.000 description 3
- 229940066842 petrolatum Drugs 0.000 description 3
- 235000019271 petrolatum Nutrition 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- FHHPUSMSKHSNKW-SMOYURAASA-M sodium deoxycholate Chemical compound [Na+].C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 FHHPUSMSKHSNKW-SMOYURAASA-M 0.000 description 3
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 2
- 235000003826 Artemisia Nutrition 0.000 description 2
- 240000002791 Brassica napus Species 0.000 description 2
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 244000030166 artemisia Species 0.000 description 2
- 235000009052 artemisia Nutrition 0.000 description 2
- 239000007933 dermal patch Substances 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 231100000021 irritant Toxicity 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 230000008099 melanin synthesis Effects 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 230000036620 skin dryness Effects 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical compound C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 description 1
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 1
- 235000003097 Artemisia absinthium Nutrition 0.000 description 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 241000167550 Centella Species 0.000 description 1
- 244000146462 Centella asiatica Species 0.000 description 1
- 235000004032 Centella asiatica Nutrition 0.000 description 1
- 239000004129 EU approved improving agent Substances 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 208000007027 Oral Candidiasis Diseases 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 241000218657 Picea Species 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 241001529742 Rosmarinus Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 241000287411 Turdidae Species 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 239000001138 artemisia absinthium Substances 0.000 description 1
- 239000001522 artemisia absinthium l. herb extract Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 230000004130 lipolysis Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 210000001640 nerve ending Anatomy 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000001691 salvia sclarea Substances 0.000 description 1
- 230000021148 sequestering of metal ion Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 230000008491 skin homeostasis Effects 0.000 description 1
- 239000003009 skin protective agent Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 239000002602 strong irritant Substances 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003700 vitamin C derivatives Chemical class 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 229940119569 wormwood extract Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/51—Chelating agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/591—Mixtures of compounds not provided for by any of the codes A61K2800/592 - A61K2800/596
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/81—Preparation or application process involves irradiation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
본 발명은 유효성분이 진피층에 도달 및 잘 흡수하도록 고주파기를 이용한 피부관리에 사용할 수 있는 기능성 화장료, 이를 제조하는 방법 및 상기 기능성 화장료를 이용한 화장품에 관한 것이다.The present invention relates to a functional cosmetic that can be used for skin care using a radio frequency machine so that active ingredients can reach and absorb well in the dermal layer, a method for manufacturing the same, and cosmetics using the functional cosmetic.
피부는 몸을 보호해주며, 외부로부터 자극을 받으면 느낄 수 있는 신경말단이 위치해 있으며 체온 조절, 비타민 합성 등의 화학적, 물리적 반응이 이루어지는 기능도 담당하고 있다.Skin protects the body, nerve endings that can be felt when stimulated from the outside are located, and is also responsible for chemical and physical reactions such as temperature control and vitamin synthesis.
피부는 크게 표피, 진피, 피하조직으로 구분된다. 진피는 표피보다 수분이 많으며 표피에 영양을 공급하여 준다. 표피에 영양이나 수분이 부족해지면 진피에서 수분과 영양을 공급하여 주기 때문에 표피층이 외부로부터 수분을 빼앗기지 않도록 피부보호와 수분을 공급해 주어야 한다. 수분 공급이 원활하지 않으면 피부 건조현상이 일어나면서 각질 세포의 결합력이 감소하여 각질층을 포함한 표피 그리고 진피의 수분 밸런스에 영양을 준다. 이러한 영향을 줄이기 위해서는 피부를 보호하고 수분과 영양을 충분히 공급해 주어야 건강한 피부를 유지할 수 있다. 특히 피부는 보이는 부분으로 미적 아름다움을 결정하는데 많은 비중을 차지하기 때문에 피부 보습 유지는 필수이다.Skin is largely divided into epidermis, dermis, and subcutaneous tissue. The dermis has more moisture than the epidermis and supplies nutrients to the epidermis. When the epidermis lacks nutrients or moisture, the dermis supplies moisture and nutrients, so it is necessary to protect the skin and supply moisture so that the epidermal layer does not lose moisture from the outside. If the supply of moisture is not smooth, the skin dries up and the binding force of the keratinocytes decreases, which nourishes the moisture balance of the epidermis and dermis including the stratum corneum. In order to reduce these effects, you need to protect your skin and supply enough moisture and nutrients to maintain healthy skin. In particular, since the skin is a visible part and takes a large part in determining aesthetic beauty, it is essential to maintain skin moisture.
피부 보습이 부족하면 대부분은 피부가 건조하다고 표현한다. 하지만, 피부 건조현상이 무조건 피부 수분함량이 감소하여 일어나는 것만은 아니다. 피부 건조현상은 피부가 건조함을 느낄 때 보습제를 수시로 발라주면 건조현상이 개선된다고 보고되어 있다. 이러한 건조현상을 개선하고자 현재까지도 피부 보습이 감소되지 않도록 유지시키기 위해 다양한 보습제를 포함한 많은 화장품이 개발, 판매되어 왔지만 지속적으로 유지하기는 힘들다는 문제점을 지니고 있다. If your skin lacks moisture, most people express that their skin is dry. However, skin dryness is not always caused by a decrease in skin moisture content. It has been reported that skin dryness can be improved by applying a moisturizer frequently when the skin feels dry. In order to improve this drying phenomenon, many cosmetics including various moisturizers have been developed and sold to maintain skin moisture so that it does not decrease, but it has a problem that it is difficult to maintain it continuously.
또한, 화장품 분야에서 가장 관심이 큰 분야 중에 하나는 피부 미백과 피부장벽이다. 피부 미백과 관련하여 가장 중요한 요소는 피부 멜라닌 색소이다. 미백 기능성 화장품은 이미 피부에 침착된 멜라닌색소의 색을 엷게 하여 피부의 미백에 도움을 주는 기능을 가진다. 미백 기능성 화장품을 개발하기 위해 다양한 기전의 기능성 원료들이 개발되고 있으며, Arbutin, Kojic acid 등의 Tyrosinase inhibition 기전의 원료가 가장 대표적이며 이 외에 vitamin C 유도체들이 국내기능성 주성분으로 고시되고 있다. 티로신 발현 억제 및 멜라좀 트랜스퍼(melanosome transfer) 억제 기전의 원료가 미백 기능성 주성분으로 고시되고 있다. 멜라닌 생성을 억제하는 합성 화합물인 하이드로퀴논이 미백화장품의 주원료로 사용되다가 발암물질로 지정되면서 최근 인체 고유의 보호기능과 항상성을 유지시켜주는 자연유래 천연성분이 기능성 화장품 소재로 각광받고 있으며, 주요 기능성 화장품의 핵심원료들이 천연추출물 또는 천연유래성분으로 바뀌고 있는 추세이다.In addition, one of the fields of greatest interest in the field of cosmetics is skin whitening and skin barrier. The most important factor related to skin whitening is skin melanin pigment. Whitening functional cosmetics have a function of helping skin whitening by thinning the color of melanin pigment already deposited on the skin. In order to develop whitening functional cosmetics, functional raw materials with various mechanisms are being developed, and raw materials with Tyrosinase inhibition mechanism such as Arbutin and Kojic acid are the most representative, and vitamin C derivatives are notified as domestic functional main ingredients. A raw material with a mechanism of inhibiting tyrosine expression and melasome transfer has been announced as a whitening functional main ingredient. Hydroquinone, a synthetic compound that inhibits melanin production, was used as a main ingredient in whitening cosmetics and was designated as a carcinogen. The core raw materials of cosmetics are changing to natural extracts or naturally derived ingredients.
본 발명은 효과적인 얼굴 지방 분해 및 축소를 위한 쉐이빙 기법에 사용되는 화장품 제조에 사용되는 최적의 조성 및 조성비를 가지는 화장료, 이의 제조방법 및 이를 포함하는 화장품을 제공하고자 한다. The present invention is intended to provide a cosmetic having an optimal composition and composition ratio used in the manufacture of cosmetics used in shaving techniques for effective facial fat decomposition and reduction, a manufacturing method thereof, and cosmetics including the same.
상술한 과제를 해결하기 위한 본 발명은 지방분해 및 피부탄력을 위한 조성 및 조성비를 가지는 고주파기를 이용한 피부관리용 기능성 화장료에 관한 발명으로서, 피부컨디셔닝제, 보습제, 금속이온봉쇄제 및 정제수를 포함하는 제1상; 카보머 수용액을 포함하는 유화안정제; 카프릴릭/카프릭트라이글리세라이드, 피부유연제, 유화제, 계면활성제, 피부흡수 촉진제, 피부보호제 및 물을 포함하는 제2상; 알지닌(Arginine) 수용액; 열수 추출물 및 알코올 추출물을 포함하는 천연식물 유래 기능성 복합추출물; 및 제3상;을 차례대로 혼합 및 용해시킨 용해액을 포함하며, 상기 제3상은 열수 추출물 및 알코올 추출물을 포함하는 천연식물 유래 기능성 복합추출물; 피부재생제, 피부탄력개선제; 피부흡수 촉진제; 피부유화제; 보습제; 현탁화제; 유화안정제; pH 조절제; 보존제; 및 향료;를 포함한다.The present invention for solving the above problems is an invention related to a functional cosmetic for skin care using a radio frequency machine having a composition and composition ratio for lipolysis and skin elasticity, comprising a skin conditioning agent, a moisturizer, a sequestering agent and purified water phase 1; Emulsion stabilizer containing carbomer aqueous solution; a second phase containing caprylic/capric triglyceride, a skin softener, an emulsifier, a surfactant, a skin absorption accelerator, a skin protectant, and water; Arginine aqueous solution; Natural plant-derived functional complex extracts including hot water extract and alcohol extract; and a third phase; a solution obtained by sequentially mixing and dissolving, wherein the third phase is a natural plant-derived functional complex extract containing a hot water extract and an alcohol extract; skin regenerating agents, skin elasticity improving agents; skin absorption accelerator; skin emulsifier; moisturizers; suspending agents; emulsion stabilizer; pH adjusting agent; preservatives; And fragrance; contains.
또한, 본 발명의 목적은 상기 화장료를 제조하는 방법에 관한 것으로서, 제1상을 반응기에 넣고, 가온 및 교반하여 제1상을 용해하여 제1용해액을 제조하는 1단계; 제1용해액에 유화안정제를 혼합 및 분산시켜서 제2용해액을 제조하는 2단계; 제2용해액에 제2상을 투입한 후, 가온 및 교반하여 제3용해액을 제조하는 3단계; 상기 제3용해액에 알지닌(Arginine) 수용액을 혼합하여 제4용해액을 제조하는 4단계; 상기 제4용해액에 제3상을 투입한 후, 교반을 수행하여 제5용해액을 제조하는 5단계; 및 제5용해액을 냉각, 탈포 처리 및 보관하는 6단계;를 포함하는 공정을 수행하여 화장료를 제조할 수 있다. In addition, an object of the present invention relates to a method for producing the cosmetic, comprising the steps of dissolving the first phase by dissolving the first phase by putting the first phase in a reactor, heating and stirring to prepare a first solution; a second step of preparing a second solution by mixing and dispersing an emulsion stabilizer in the first solution; Step 3 of preparing a third solution by heating and stirring after adding the second phase to the second solution; a fourth step of preparing a fourth solution by mixing an aqueous solution of arginine with the third solution; Step 5 of preparing a fifth solution by adding a third phase to the fourth solution and then performing stirring; And a sixth step of cooling, degassing, and storing the fifth lysate. Cosmetics can be manufactured by performing a process including.
또한, 본 발명의 다른 목적은 상기 화장료를 포함하는 에멀젼, 로션 및/또는 크림 제형의 화장품을 제공하는데 있다.In addition, another object of the present invention is to provide cosmetics of emulsion, lotion and / or cream formulations containing the cosmetic.
본 발명의 기능성 화장료는 피부 트러블이 없으면서, 피부 보습성, 미백, 항산화, 피부 탄력 개선 및 피부 진정 효과가 우수하며,피부 흡수력이 한 바, 얼굴 지방 분해 및 축소를 위한 쉐이빙 기법에 따른 피부 관리시 적용하기 적합하며, 이러한 본 발명의 기능성 화장료는 스킨, 에멀젼, 로션 또는 크림 제형의 다양한 화장품의 화장료로 사용할 수 있으며, 고주파기를 이용한 피부 관리시 사용되는 화장품으로서 사용하여 기능성 유효성분의 피부 흡수력을 크게 증대시킬 수 있다.The functional cosmetic of the present invention has excellent skin moisturizing, whitening, antioxidant, skin elasticity improvement and skin soothing effects without skin trouble, and has excellent skin absorption, so it can be used for skin care according to shaving techniques for decomposition and reduction of facial fat. It is suitable for application, and the functional cosmetic of the present invention can be used as a cosmetic for various cosmetics in the form of skin, emulsion, lotion or cream, and can be used as a cosmetic used for skin care using a high frequency device to increase the skin absorption of functional active ingredients. can increase
본 발명은 고주파기를 이용한 피부관리용 기능성 화장료에 관한 발명으로서, 피부컨디셔닝제, 보습제, 금속이온봉쇄제 및 정제수를 포함하는 제1상; 카보머 수용액을 포함하는 유화안정제; 카프릴릭/카프릭트라이글리세라이드, 피부유연제, 유화제, 계면활성제, 피부흡수 촉진제, 피부보호제 및 물을 포함하는 제2상; 알지닌(Arginine) 수용액; 천연식물 유래 기능성 복합추출물; 및 제3상;을 차례대로 혼합 및 용해시킨 용해액을 포함한다.The present invention relates to a functional cosmetic for skin care using a radio frequency machine, comprising: a first phase comprising a skin conditioning agent, a moisturizer, a sequestering agent and purified water; Emulsion stabilizer containing carbomer aqueous solution; a second phase containing caprylic/capric triglyceride, a skin softener, an emulsifier, a surfactant, a skin absorption accelerator, a skin protectant, and water; Arginine aqueous solution; Functional complex extracts derived from natural plants; and a third phase; and a solution obtained by mixing and dissolving in turn.
본 발명의 화장료는 상기 제1상 15.0 ~ 19.0 중량%, 상기 카보머 수용액 1.50 ~ 2.50 중량%, 상기 제2상 60.0 ~ 65.0 중량%, 상기 알지닌 수용액 2,50 ~ 3,50 중량% 및 100 중량% 중 나머지 잔량의 상기 제3상을 포함할 수 있으며, 바람직하게는 상기 제1상 16.5 ~ 17.5 중량%, 상기 카보머 수용액 1.80 ~ 2.25 중량%, 상기 제2상 62.00 ~ 64.00 중량%, 상기 알지닌 수용액 2.70 ~ 3.10 중량% 및 100 중량% 중 나머지 잔량의 상기 제3상을 포함할 수 있고, 더욱 바람직하게는 상기 제1상 16.80 ~ 17.40 중량%, 상기 카보머 수용액 1.90 ~ 2.20 중량%, 상기 제2상 62.5 ~ 64.0 중량%, 상기 알지닌 수용액 2.80 ~ 3.10 중량% 및 100 중량% 중 나머지 잔량의 상기 제3상을 포함할 수 있다.The cosmetic composition of the present invention comprises 15.0 to 19.0% by weight of the first phase, 1.50 to 2.50% by weight of the carbomer aqueous solution, 60.0 to 65.0% by weight of the second phase, 2,50 to 3,50% by weight of the arginine aqueous solution and 100 The remaining amount of the third phase may be included in the remaining weight%, preferably 16.5 to 17.5% by weight of the first phase, 1.80 to 2.25% by weight of the carbomer aqueous solution, 62.00 to 64.00% by weight of the second phase, 2.70 to 3.10% by weight of the arginine aqueous solution and 100% by weight of the remaining third phase, more preferably 16.80 to 17.40% by weight of the first phase, 1.90 to 2.20% by weight of the aqueous carbomer solution, 62.5 to 64.0% by weight of the second phase, 2.80 to 3.10% by weight of the arginine aqueous solution, and 100% by weight of the remaining balance of the third phase.
본 발명의 상기 화장료는 제1상을 반응기에 넣고, 가온 및 교반하여 제1상을 용해하여 제1용해액을 제조하는 1단계; 제1용해액에 유화안정제를 혼합 및 분산시켜서 제2용해액을 제조하는 2단계; 제2용해액에 제2상을 투입한 후, 가온 및 교반하여 제3용해액을 제조하는 3단계; 상기 제3용해액에 알지닌(Arginine) 수용액을 혼합하여 제4용해액을 제조하는 4단계; 상기 제4용해액에 제3상을 투입한 후, 교반을 수행하여 제5용해액을 제조하는 5단계; 및 제5용해액을 냉각, 탈포처리 및 보관하는 6단계;를 포함하는 공정을 수행하여 제조할 수 있다. The cosmetic of the present invention includes a first step of preparing a first dissolved solution by dissolving the first phase by putting the first phase in a reactor, heating and stirring; a second step of preparing a second solution by mixing and dispersing an emulsion stabilizer in the first solution; Step 3 of preparing a third solution by heating and stirring after adding the second phase to the second solution; a fourth step of preparing a fourth solution by mixing an aqueous solution of arginine with the third solution; Step 5 of preparing a fifth solution by adding a third phase to the fourth solution and then performing stirring; It can be prepared by performing a process including; and a sixth step of cooling, degassing, and storing the fifth lysate.
1단계의 상기 제1상은 피부컨디셔닝제, 보습제, 금속이온봉쇄제 및 정제수를 반응기에 투입한 후, 60 ~ 75℃로, 바람직하게는 65 ~ 75℃로 가온 및 천천히 교반시켜서 제1상을 용해하여 제1용해액을 제조한다. 이때, 60℃ 미만으로 가온시, 제1상의 혼합액 내 성분들이 용매에 잘 용해되지 않을 수 있으며, 80℃를 초과하는 것은 비경제적이다.The first phase of step 1 is a skin conditioning agent, a moisturizer, a sequestering agent, and purified water are added to a reactor, and then heated to 60 to 75 ° C., preferably 65 to 75 ° C. and stirred slowly to dissolve the first phase. to prepare a first solution. At this time, when heated to less than 60 ° C, components in the mixed solution of the first phase may not dissolve well in the solvent, and it is uneconomical to exceed 80 ° C.
제1상의 피부컨디셔닝제는 알란토인(Allantoin) 및 트라넥삼산(tranexamic acid) 중에서 선택된 1종 이상을 포함하며, 바람직하게는 알란토인 및 트라넥삼산을 포함할 수 있으며, 더욱 바람직하게는 알란토인 및 트라넥삼산을 포함할 수 있다. 상기 알란토인은 항자극제, 피부재생 역할을 하며, 상기 트라넥삼산은 프로프사글란딘을 억제하여 멜라닌 생성 억제를 통한 피부 미백 효과를 부여하는 역할을 하는 것으로서, 알란토인 및 트라넥삼산을 혼합 사용시에는 1 : 10 ~ 30 중량비로, 바람직하게는 알란토인 및 트라넥삼산을 1 : 15 ~ 25 중량비로, 더욱 바람직하게는 알란토인 및 트라넥삼산을 1 : 18 ~ 24 중량비로 혼합하여 사용하는 것이 좋다. 이때, 트라넥삼산 사용량이 10 중량비 미만이면 피부 미백 효과가 부족할 수 있고, 30 중량비를 초과하면 피부 트러블을 유발할 수 있으므로 상기 범위 내로 사용하는 것이 좋다.The first phase skin conditioning agent includes at least one selected from allantoin and tranexamic acid, preferably allantoin and tranexamic acid, more preferably allantoin and tranexamic acid may contain triacids. The allantoin acts as an anti-irritant and skin regeneration, and the tranexamic acid inhibits propsaglandin to impart a skin whitening effect through inhibition of melanin production. : In a weight ratio of 10 to 30, preferably, allantoin and tranexamic acid are mixed in a weight ratio of 1: 15 to 25, more preferably, allantoin and tranexamic acid are mixed in a weight ratio of 1: 18 to 24. At this time, if the amount of tranexamic acid used is less than 10 weight ratio, the skin whitening effect may be insufficient, and if it exceeds 30 weight ratio, it may cause skin trouble, so it is preferable to use it within the above range.
그리고, 제1상 내 피부컨디셔닝제의 사용량은 상기 정제수 100 중량부에 대하여, 15 ~ 35 중량부를, 바람직하게는 17.5 ~ 30 중량부를, 더욱 바람직하게는 19.0 ~ 25,0 중량부를 포함할 수 있다. 이때 피부컨디셔닝제 사용량이 15 중량부 미만이면 피부 미백 효과가 미비할 수 있으며, 35 중량부를 초과하여 사용하면 피부 트러블이 발생할 수 있으므로 상기 범위 내로 사용하는 것이 좋다.In addition, the amount of skin conditioning agent in the first phase may include 15 to 35 parts by weight, preferably 17.5 to 30 parts by weight, more preferably 19.0 to 25.0 parts by weight, based on 100 parts by weight of the purified water. . At this time, if the amount of the skin conditioning agent is less than 15 parts by weight, the skin whitening effect may be insufficient, and if it is used in excess of 35 parts by weight, skin trouble may occur, so it is recommended to use it within the above range.
제1상 성분 중 상기 보습제는 글리세린 및 다이프로필렌글라이콜 중에서 선택된 1종 이상을 포함할 수 있고, 바람직하게는 글리세린 및 다이프로필렌글라이콜 1:0.5 ~ 1.0 중량비로, 더욱 바람직하게는 글리세린 및 다이프로필렌글라이콜 1:0.6 ~ 0.8 중량비로 포함할 수 있다. 그리고, 제1상 내 보습제의 사용량은 상기 정제수 100 중량부에 대하여, 80 ~ 130 중량부를, 바람직하게는 100 ~ 125 중량부를, 더욱 바람직하게는 105 ~ 120 중량부를 포함할 수 있다. Among the first-phase ingredients, the humectant may include at least one selected from glycerin and dipropylene glycol, preferably glycerin and dipropylene glycol in a weight ratio of 1:0.5 to 1.0, more preferably glycerin and dipropylene glycol. Dipropylene glycol may be included in a weight ratio of 1:0.6 to 0.8. In addition, the amount of the humectant in the first phase may include 80 to 130 parts by weight, preferably 100 to 125 parts by weight, and more preferably 105 to 120 parts by weight, based on 100 parts by weight of the purified water.
제1상 성분 중 금속이온봉쇄제는 화장품 업계에서 사용하는 일반적인 금속이온 봉쇄제를 사용할 수 있으며, 바람직하게는 다이소듐이디티에이(Disodium EDTA), 스트르산의 나트륨염 및 카프릴하이드록삼산의 염 중에서 선택된 1종 이상을 포함할 수 있고, 더욱 바람직하게는 다이소듐이디티에이를 포함할 수 있다. 그리고, 제1상 내 이의 함량은 상기 정제수 100 중량부에 대하여, 1 ~ 5 중량부를, 바람직하게는 1.2 ~ 3.5 중량부를 사용할 수 있다.Among the first-phase components, the sequestering agent may be a sequestering agent used in the cosmetics industry, preferably disodium EDTA, sodium salt of stric acid, and caprylic hydroxamic acid. It may include one or more selected from among salts, and more preferably may include disodium EDTA. And, its content in the first phase may be 1 to 5 parts by weight, preferably 1.2 to 3.5 parts by weight, based on 100 parts by weight of the purified water.
본 발명 화장료 제조방법의 2단계는 1단계에서 제조한 제1용해액에 카보머 수용액을 포함하는 유화안정제를 투입한 후, 60 ~ 80℃로, 바람직하게는 65 ~ 75℃ 하에서 교반속도 900 ~ 1200 rpm 하에서 5분 ~ 20분간, 바람직하게는 900 ~ 1100 rpm 하에서 10분 ~ 15분 정도 수행하여 제2용해액을 제조하는 공정이다. 이때, 교반속도가 900 rpm 미만이거나 교반 시간이 5분 미만이면 카보머 수용액에 제1용해액에 잘 용해되지 않을 수 있으며, 교반속도가 1200 rpm을 초과하면 기포가 발생할 수 있고, 교반 시간이 20분을 초과하는 것은 비경제적이다.In the second step of the cosmetic preparation method of the present invention, the emulsion stabilizer containing the carbomer aqueous solution is added to the first solution prepared in the first step, and then stirred at 60 ~ 80 ℃, preferably 65 ~ 75 ℃, stirring speed 900 ~ It is a process of preparing a second solution by carrying out 5 to 20 minutes at 1200 rpm, preferably 10 to 15 minutes at 900 to 1100 rpm. At this time, if the stirring speed is less than 900 rpm or the stirring time is less than 5 minutes, the carbomer aqueous solution may not be dissolved well in the first solution, and if the stirring speed exceeds 1200 rpm, bubbles may be generated, and the stirring time is 20 Exceeding the minute is uneconomical.
그리고, 상기 카보머 수용액은 카보머 2.0 ~ 5.0 중량% 및 나머지 잔량의 물을 포함할 수 있으며, 바람직하게는 카보머 2.0 ~ 3.5 중량% 및 나머지 잔량의 물을 포함할 수 있다. The carbomer aqueous solution may include 2.0 to 5.0 wt% of carbomer and the remaining amount of water, preferably 2.0 to 3.5 wt% of carbomer and the remaining amount of water.
다음으로, 본 발명 화장료 제조방법의 3단계는 제2용해액에 제2상을 투입한 후, 가온하여 제3용해액을 제조하는 공정이다. 이때, 가온은 75 ~ 85℃로 바람직하게는 78 ~ 85℃로, 더욱 바람직하게는 80 ~ 85℃로 하는 것이 좋으며, 이때, 75℃ 미만으로 가온시, 제2상이 제2용해액에 잘 용해되지 않을 수 있으며, 85℃를 초과하는 것은 비경제적이며, 화장료 변질을 유발할 수 있다. 이때, 가온과 함께 교반을 수행하여 제3용해액을 제조하며, 교반속도 500 ~ 800 rpm 하에서 5분 ~ 15분간, 바람직하게는 교반속도 550 ~ 650 rpm 로 8분 ~ 15분간 수행하는 것이 좋다.Next, the third step of the cosmetic preparation method of the present invention is a process of preparing a third solution by adding the second phase to the second solution and then heating it. At this time, the heating is preferably 75 ~ 85 ℃, preferably 78 ~ 85 ℃, more preferably 80 ~ 85 ℃, at this time, when heated to less than 75 ℃, the second phase dissolves well in the second solution It may not be, and exceeding 85 ° C is uneconomical and may cause deterioration of cosmetics. At this time, a third solution is prepared by stirring together with heating, and stirring is performed for 5 to 15 minutes at a stirring speed of 500 to 800 rpm, preferably for 8 to 15 minutes at a stirring speed of 550 to 650 rpm.
그리고, 상기 제2상은 카프릴릭/카프릭트라이글리세라이드, 피부유연제, 유화제, 계면활성제, 피부흡수 촉진제, 피부보호제 및 물을 포함하며, 바람직하게는 카프릴릭/카프릭트라이글리세라이드 100 중량부에 대하여, 피부유연제 9.0 ~ 15.0 중량부, 유화제 4.0 ~ 8.5 중량부, 계면활성제 0.8 ~ 1.7 중량부, 피부흡수 촉진제 0.20 ~ 0.40 중량부, 피부보호제 0.30 ~ 1.2 중량부 및 물 20.0 ~ 25.0 중량부를 포함할 수 있고, 바람직하게는 카프릴릭/카프릭트라이글리세라이드 100 중량부에 대하여, 피부유연제 12.5 ~ 15.0 중량부, 유화제 4.5 ~ 7.5 중량부, 계면활성제 0.9 ~ 1.5 중량부, 피부흡수 촉진제 0.25 ~ 0.35 중량부, 피부보호제 0.40 ~ 1.0 중량부 및 물 21.0 ~ 24.0 중량부를 포함할 수 있으며, 더욱 바람직하게는 카프릴릭/카프릭트라이글리세라이드 100 중량부에 대하여, 피부유연제 13.5 ~ 15.0 중량부, 유화제 5.2 ~ 6.2 중량부, 계면활성제 1.0 ~ 1.2 중량부, 피부흡수 촉진제 0.25 ~ 0.32 중량부, 피부보호제 0.43 ~ 0.75 중량부 및 물 22.0 ~ 24.0 중량부를 포함할 수 있다.And, the second phase includes caprylic/capric triglyceride, a skin softener, an emulsifier, a surfactant, a skin absorption accelerator, a skin protectant, and water, preferably 100 weight of caprylic/capric triglyceride 9.0 to 15.0 parts by weight of skin softener, 4.0 to 8.5 parts by weight of emulsifier, 0.8 to 1.7 parts by weight of surfactant, 0.20 to 0.40 part by weight of skin absorption promoter, 0.30 to 1.2 parts by weight of skin protectant and 20.0 to 25.0 parts by weight of water 12.5 to 15.0 parts by weight of skin softener, 4.5 to 7.5 parts by weight of emulsifier, 0.9 to 1.5 parts by weight of surfactant, 0.25 part by weight of skin absorption accelerator, based on 100 parts by weight of caprylic/capric triglyceride. ~ 0.35 parts by weight, 0.40 ~ 1.0 parts by weight of skin protectant, and 21.0 ~ 24.0 parts by weight of water, more preferably 13.5 ~ 15.0 parts by weight of skin softener based on 100 parts by weight of caprylic/capric triglyceride , 5.2 to 6.2 parts by weight of an emulsifier, 1.0 to 1.2 parts by weight of a surfactant, 0.25 to 0.32 parts by weight of a skin absorption accelerator, 0.43 to 0.75 parts by weight of a skin protectant, and 22.0 to 24.0 parts by weight of water.
제2상 성분 중 상기 피부유연제는 세틸에틸헥사노에이트(CetylEthylhexanoate) 및 에틸헥실팔미테이트(Ethylhexyl Palmitate) 중에서 선택된 1종 이상을 포함할 수 있고, 바람직하게는 세틸에틸헥사노에이트 및 에틸헥실팔미테이트를 혼합하여 사용할 수 있고, 바람직하게는 세틸에틸헥사노에이트 및 에틸헥실팔미테이트를 1 : 0.1 ~ 0.3 중량비로 포함하는 것이 피부유연 효과 측면에서 좋다.Among the second-phase ingredients, the skin softener may include at least one selected from CetylEthylhexanoate and Ethylhexyl Palmitate, preferably cetylethylhexanoate and ethylhexylpalmitate may be mixed and used, and preferably cetylethylhexanoate and ethylhexylpalmitate are included in a weight ratio of 1:0.1 to 0.3, which is good in terms of skin softening effect.
제2상 성분 중 상기 유화제는 세테아릴알코올(Cetearyl Alcohol), 솔비탄세스퀴올리에이트(SorbitanSesquioleate), 피이지-100스테아레이트(PEG-100 Stearate) 및 솔비탄스테아레이트(Sorbitan Stearate) 중에서 선택된 1종 이상을 포함할 수 있고, 바람직하게는 세테아릴알코올, 솔비탄세스퀴올리에이트, 피이지-100스테아레이트 및 솔비탄스테아레이트 중에서 선택된 2종 이상을 포함할 수 있으며, 더욱 바람직하게는 세테아릴알코올, 솔비탄세스퀴올리에이트, 피이지-100스테아레이트 및 솔비탄스테아레이트 4종을 모두 혼합하여 사용할 수 있다.Among the components of the second phase, the emulsifier is selected from Cetearyl Alcohol, Sorbitan Sesquioleate, PEG-100 Stearate and Sorbitan Stearate. It may contain one or more, preferably two or more selected from cetearyl alcohol, sorbitan sesquioleate, PEG-100 stearate and sorbitan stearate, more preferably All four types of cetearyl alcohol, sorbitan sesquioleate, PEG-100 stearate and sorbitan stearate may be mixed and used.
제2상 성분 중 상기 계면활성제는 폴리솔베이트60(Polysorbate 60) 및 글리세릴스테아레이트(Glyceryl Stearate) 중에서 선택된 1종 이상을 포함하고, 바람직하게는 폴리솔베이트60 및 글리세릴스테아레이트를 1 : 0.1 ~ 0.3 중량비로 혼합하여 사용하는 것이 제2상 성분들간의 혼화성 및 제1상과 제3상 성분들과의 혼화성 측면에서 좋다.Among the second-phase components, the surfactant includes at least one selected from polysorbate 60 and glyceryl stearate, and preferably polysorbate 60 and glyceryl stearate are mixed in 1: Mixing at a weight ratio of 0.1 to 0.3 is good in terms of miscibility between the second phase components and miscibility between the first and third phase components.
제2상 성분 중 상기 피부흡수 촉진제는 상기 피부보호제 및 피부컨디셔닝제의 피부 흡수를 촉진하는 역할을 하는 것으로서, 페트롤라툼(Petrolatum)을 포함할 수 있다.Among the second-phase components, the skin absorption accelerator serves to promote skin absorption of the skin protecting agent and skin conditioning agent, and may include petrolatum.
제2상 성분 중 상기 피부보호제는 다이메티콘(Dimethicone), 마카다미아씨 오일(Macadamia Ternifolia Seed Oil) 및 토코페릴아세테이트(Tocopheryl Acetate) 중에서 선택된 1종 이상을 포함할 수 있으며, 바람직하게는 다이메티콘, 마카다미아씨 오일 및 토코페릴아세테이트를 1 : 0.1~0.3 : 0.2~0.5 중량비로 포함할 수 있다.Among the second-phase components, the skin protectant may include at least one selected from dimethicone, macadamia ternifolia seed oil, and tocopheryl acetate, preferably dimethicone. , Macadamia seed oil and tocopheryl acetate may be included in a weight ratio of 1: 0.1 to 0.3: 0.2 to 0.5.
그리고, 제2상 성분 중 상기 물은 용매 역할을 한다.And, among the second-phase components, the water serves as a solvent.
다음으로, 본 발명 화장료 제조방법의 4단계는 알지닌(Arginine) 수용액을 혼합하여 제4용해액을 제조하는 공정으로서, 상기 알지닌 수용액은 피부컨디셔닝제의 일종이다. 그리고, 상기 알지닌 수용액은 알지닌 1.0 ~ 5.0 중량% 및 나머지 잔량의 물을 포함할 수 있고, 바람직하게는 알지닌 1.3 ~ 3.0 중량% 및 나머지 잔량의 물을, 더욱 바람직하게는 알지닌 1.4 ~ 2.0 중량% 및 나머지 잔량의 물을 포함할 수 있다. Next, step 4 of the cosmetic preparation method of the present invention is a process of preparing a fourth lysate by mixing an arginine aqueous solution, and the arginine aqueous solution is a type of skin conditioning agent. In addition, the aqueous arginine solution may include 1.0 to 5.0% by weight of arginine and the remaining amount of water, preferably 1.3 to 3.0% by weight of arginine and the remaining amount of water, more preferably 1.4 to 3.0% by weight of arginine. 2.0% by weight and the remaining balance of water.
다음으로, 본 발명 화장료 제조방법의 5단계는 상기 제4용해액에 제3상을 투입한 후, 40 ~ 50℃에서 교반을 수행하여 제5용해액을 제조하는 공정이다. 5단계의 교반 및 용해는 교반속도 650 ~ 800 rpm 및 40 ~ 50℃ 하에서 2분 ~ 10분간, 바람직하게는 650 ~ 750 rpm 및 40 ~ 45℃ 하에서 3분 ~ 6분간 수행하는 것이 좋다. Next, step 5 of the cosmetic preparation method of the present invention is a step of preparing a fifth solution by adding the third phase to the fourth solution and stirring at 40 to 50 ° C. Stirring and dissolving in step 5 is preferably carried out at a stirring speed of 650 to 800 rpm and 40 to 50 ° C for 2 to 10 minutes, preferably at 650 to 750 rpm and 40 to 45 ° C for 3 to 6 minutes.
상기 제3상은 천연식물 유래 기능성 복합추출물; 피부재생제; 피부탄력개선제; 피부흡수 촉진제; 피부유화제; 보습제; 현탁화제; 유화안정제; pH 조절제; 보존제; 및 향료;를 포함하고, 바람직하게는 천연식물 유래 기능성 복합추출물 38.0 ~ 45.0 중량%, 피부재생제 0.2 ~ 1.5 중량%, 피부탄력개선제 0.5 ~ 1.7 중량% 피부흡수 촉진제 0.3 ~ 0.8 중량%, 피부유화제 0.2 ~ 1.0 중량%, 보습제 30.0 ~ 42.0 중량%, 현탁화제 0.2 ~ 1.0 중량%, 유화안정제 0.2 ~ 1.0 중량% pH 조절제 0.1 ~ 0.8 중량%, 향료 5.0 ~ 10.0 및 100 중량% 중 나머진 잔량의 보존제를 포함할 수 있고, 더욱 바람직하게는 천연식물 유래 기능성 복합추출물 39.0 ~ 43.0 중량%, 피부재생제 0.3 ~ 1.0 중량%, 피부탄력개선제 0.7 ~ 1.2 중량% 피부흡수 촉진제 0.3 ~ 0.7 중량%, 피부유화제 0.3 ~ 1.0 중량%, 보습제 32.0 ~ 41.0 중량%, 현탁화제 0.3 ~ 1.0 중량% 유화안정제 0.3 ~ 0.8 중량%, pH 조절제 0.2 ~ 0.7 중량%, 향료 5.0 ~ 9.0 및 100 중량% 중 나머진 잔량의 보존제를 포함할 수 있다.The third phase is a functional complex extract derived from natural plants; skin regeneration agent; skin elasticity improving agent; skin absorption accelerator; skin emulsifier; moisturizers; suspending agents; emulsion stabilizer; pH adjusting agent; preservatives; and fragrance; preferably, 38.0 to 45.0% by weight of a functional complex extract derived from natural plants, 0.2 to 1.5% by weight of a skin regenerating agent, 0.5 to 1.7% by weight of a skin elasticity improving agent, 0.3 to 0.8% by weight of a skin absorption promoter, and 0.3 to 0.8% by weight of a skin emulsifying agent 0.2 to 1.0% by weight, humectant 30.0 to 42.0% by weight, suspending agent 0.2 to 1.0% by weight, emulsion stabilizer 0.2 to 1.0% by weight pH adjusting agent 0.1 to 0.8% by weight, fragrance 5.0 to 10.0 and 100% by weight of the remainder of the preservative 39.0 to 43.0% by weight of a functional complex extract derived from natural plants, 0.3 to 1.0% by weight of a skin regenerating agent, 0.7 to 1.2% by weight of a skin elasticity improving agent, 0.3 to 0.7% by weight of a skin absorption accelerator, and 0.3% by weight of a skin emulsifier. ~ 1.0% by weight, moisturizer 32.0 ~ 41.0% by weight, suspending agent 0.3 ~ 1.0% by weight, emulsification stabilizer 0.3 ~ 0.8% by weight, pH adjusting agent 0.2 ~ 0.7% by weight, fragrance 5.0 ~ 9.0 and 100% by weight, including the rest of the preservative can do.
그리고, 상기 제3상은 고압액상유화기(micro fluidizer, 또는 초고압분산기)를 이용하여 천연식물 유래 기능성 복합추출물, 피부재생제, 피부탄력개선제, 피부흡수 촉진제, 피부유화제, 보습제, 현탁화제, 유화안정제, pH 조절제, 보존제, 및 향료를 균질하게 혼합하고, 약 12,000 ~ 18,000 psi 압력, 바람직하게는 13,500 ~ 16,500 psi 압력 하에서 미분화시킨 에멀젼화된 액상화시킨 것일 수 있다.In addition, the third phase is a natural plant-derived functional complex extract, skin regenerating agent, skin elasticity improving agent, skin absorption accelerator, skin emulsifier, moisturizer, suspending agent, emulsion stabilizer , pH adjusting agent, preservative, and flavor may be homogeneously mixed and micronized under a pressure of about 12,000 to 18,000 psi, preferably 13,500 to 16,500 psi, and then emulsified and liquefied.
또한, 제3상 성분 중 상기 천연식물 유래 기능성 복합추출물은 열수 추출물 및 알코올 추출물을 포함하며, 바람직하게는 열수 추출물 및 알코올 추출물을 1 : 0.2 ~ 0.5 중량비로 포함하고, 더욱 바람직하게는 열수 추출물 및 알코올 추출물을 1 : 0.25 ~ 0.35 중량비로 포함한다.In addition, among the third-phase ingredients, the natural plant-derived functional complex extract includes a hot water extract and an alcohol extract, preferably a hot water extract and an alcohol extract in a weight ratio of 1: 0.2 to 0.5, more preferably a hot water extract and an alcohol extract. Alcohol extract is included in a weight ratio of 1:0.25 to 0.35.
상기 열수 추출물은 천연식물을 열수 추출, 바람직하게는 진공 저온 추출 공법을 통해 제조한 열수 추출물일 수 있다. 그리고, 상기 열수 추출물은, 라벤더꽃추출물, 클레리추출물(Salvia Sclarea Extract), 히아신스전초추출물(Hyacinthus Orientalis Extract), 보리지추출물(Borago Officinalis Extract), 귤추출물(Citrus Unshiu Fruit Extract), 유자추출물(Citrus Junos Fruit Extract), 녹차잎추출물, 포트마리골드꽃추출물(Calendula Officinalis Flower Extract), 로즈마리추출물(Rosemary Extract), 당느릅나무껍질추출물 (UlmusCampestris Bark Extract), 민들레전초추출물(TaraxacumPlatycarpum Extract), 개똥쑥추출물(Artemisia Annua Extract) 및 쇠비름추출물(PortulacaOleracea Extract)을 포함하며, 바람직하게는 라벤더꽃추출물 100 중량부에 대하여, 클레리추출물 50 ~ 150 중량부, 히아신스전초추출물 50 ~ 120 중량부, 보리지추출물 70 ~ 130 중량부, 귤추출물 50 ~ 150 중량부, 유자추출물 50 ~ 150 중량부, 녹차잎추출물 70 ~ 120 중량부, 포트마리골드꽃추출물 50 ~ 120 중량부, 로즈마리추출물 70 ~ 120 중량부, 당느릅나무껍질추출물 50 ~ 150 중량부, 민들레전초추출물 80 ~ 130 중량부, 개똥쑥추출물 70 ~ 120 중량부 및 쇠비름추출물 50 ~ 110 중량부를 포함할 수 있고, 더욱 바람직하게는 라벤더꽃추출물 100 중량부에 대하여, 클레리추출물 50 ~ 110 중량부, 히아신스전초추출물 80 ~ 120 중량부, 보리지추출물 90 ~ 130 중량부, 귤추출물 70 ~ 130 중량부, 유자추출물 70 ~ 130 중량부, 녹차잎추출물 75 ~ 110 중량부, 포트마리골드꽃추출물 80 ~ 110 중량부, 로즈마리추출물 85 ~ 105 중량부, 당느릅나무껍질추출물 80 ~ 150 중량부, 민들레전초추출물 80 ~ 110 중량부, 개똥쑥추출물 80 ~ 110 중량부 및 쇠비름추출물 60 ~ 105 중량부를 포함할 수 있다.The hot-water extract may be a hot-water extract prepared by hot-water extraction of natural plants, preferably through a vacuum low-temperature extraction method. In addition, the hot water extract, lavender flower extract, Clary extract (Salvia Sclarea Extract), hyacinth extract (Hyacinthus Orientalis Extract), borage extract (Borago Officinalis Extract), tangerine extract (Citrus Unshiu Fruit Extract), citron extract ( Citrus Junos Fruit Extract), Green Tea Leaf Extract, Calendula Officinalis Flower Extract, Rosemary Extract, Ulmus Campestris Bark Extract, Taraxacum Platycarpum Extract, Wild Artemisia Contains extract (Artemisia Annua Extract) and purslane extract (PortulacaOleracea Extract), preferably, based on 100 parts by weight of lavender flower extract, 50 to 150 parts by weight of clary extract, 50 to 120 parts by weight of hyacinth extract, borage extract 70 to 130 parts by weight, tangerine extract 50 to 150 parts by weight, citron extract 50 to 150 parts by weight, green tea leaf extract 70 to 120 parts by weight, port marigold flower extract 50 to 120 parts by weight, rosemary extract 70 to 120 parts by weight, 50 to 150 parts by weight of elm bark extract, 80 to 130 parts by weight of dandelion spruce extract, 70 to 120 parts by weight of artemisia extract, and 50 to 110 parts by weight of purslane extract, more preferably 100 parts by weight of lavender flower extract About parts, 50 to 110 parts by weight of clary extract, 80 to 120 parts by weight of hyacinth extract, 90 to 130 parts by weight of borage extract, 70 to 130 parts by weight of tangerine extract, 70 to 130 parts by weight of citron extract, green tea leaf extract 75 ~ 110 parts by weight, port marigold flower extract 80 ~ 110 parts by weight, rosemary extract 85 ~ 105 parts by weight, elm bark extract 80 ~ 150 parts by weight, dandelion outpost extract 80 ~ 110 It may include 80 to 110 parts by weight of wormwood extract and 60 to 105 parts by weight of purslane extract.
그리고, 상기 열수 추출물은 라벤더꽃, 클레리, 히아신스전초, 보리지, 귤, 유자, 녹차잎, 포트마리골드꽃, 로즈마리, 당느릅나무껍질, 민들레전초, 개똥쑥 및 쇠비름 각각에 대한 열수 추출물을 상기 비율로 혼합한 혼합물이거나, 또는 이들을 상기 비율로 혼합한 식물 혼합물에 대한 열수 추출물일 수 있다.In addition, the hot water extract is a hot water extract for each of lavender flower, clary, hyacinth herb, borage, tangerine, citron, green tea leaf, port marigold flower, rosemary, elm bark, dandelion herb, wormwood and purslane It may be a mixture mixed at the above ratio, or a hot water extract for a plant mixture mixed at the above ratio.
또한, 상기 알코올 추출물은 에탄올 추출물로서, 수레국화꽃추출물(CentaureaCyanus Flower Extract), 유채꽃추출물(Brassica Campestris Flower Extract), 마트리카리아꽃추출물(ChamomillaRecutita Flower Extract), 흰목이버섯추출물(TremellaFuciformis Extract) 및 스타아니스추출물(IlliciumVerum Fruit Extract) 중에서 선택된 3종 이상을 포함할 수 있고, 바람직하게는 수레국화꽃추출물 100 중량부에 대하여 유채꽃추출물 50 ~ 150 중량부, 마트리카리아꽃추출물 70 ~ 120 중량부, 흰목이버섯추출물 50 ~ 150 중량부 및 스타아니스추출물 90 ~ 150 중량부를 포함할 수 있고, 더욱 바람직하게는 수레국화꽃추출물 100 중량부에 대하여 유채꽃추출물 80 ~ 120 중량부, 마트리카리아꽃추출물 90 ~ 120 중량부, 흰목이버섯추출물 50 ~ 110 중량부 및 스타아니스추출물 90 ~ 110 중량부를 포함할 수 있다.In addition, the alcohol extract is an ethanol extract, cornflower extract (CentaureaCyanus Flower Extract), rape flower extract (Brassica Campestris Flower Extract), matricaria flower extract (Chamomilla Recutita Flower Extract), white mushroom extract (Tremella Fuciformis Extract), and It may contain three or more species selected from star anise extract (IlliciumVerum Fruit Extract), preferably 50 to 150 parts by weight of rape flower extract and 70 to 120 parts by weight of matricaria flower extract based on 100 parts by weight of cornflower extract. , 50 to 150 parts by weight of white throat mushroom extract and 90 to 150 parts by weight of star anise extract, more preferably 80 to 120 parts by weight of rapeseed flower extract and 80 to 120 parts by weight of cornflower flower extract based on 100 parts by weight of cornflower flower extract 90 to 120 parts by weight of the extract, 50 to 110 parts by weight of the white throat mushroom extract, and 90 to 110 parts by weight of the star anise extract.
그리고, 상기 알코올 추출물은 수레국화꽃, 유채꽃, 마트리카리아꽃, 흰목이버섯 및 스타아니스추출물 각각에 대한 에탄올 추출물을 상기 비율로 혼합한 혼합물이거나, 또는 이들을 상기 비율로 혼합한 식물 혼합물에 대한 에탄올 추출물일 수 있다.In addition, the alcohol extract is a mixture obtained by mixing ethanol extracts of cornflower flower, rapeseed flower, matricaria flower, white throat mushroom, and star anise extract, respectively, in the above ratio, or a plant mixture obtained by mixing them in the above ratio. It may be an ethanol extract.
제3상 성분 중 상기 피부재생제는 당업계에서 사용하는 피부 안정성이 인정된 피부재생성분을 사용할 수 있고, 바람직하게는 병풀 유래 성분인 아시아티코사이드를 사용할 수 있다. Among the third-phase ingredients, the skin regeneration agent may use a skin regeneration ingredient recognized for skin stability used in the art, and preferably, asiaticoside, a component derived from centella asiatica.
제3상 성분 중 상기 피부탄력개선제는 소듐디옥시콜레이트(Sodium Deoxycholate) 및 티옥트산(Thioctic Acid) 중에서 선택된 1종 이상을 포함하고, 바람직하게는 소듐디옥시콜레이트 및 티옥트산을 1 : 1 ~ 2 중량비로 포함할 수 있다.Among the third-phase ingredients, the skin elasticity improving agent includes at least one selected from sodium deoxycholate and thioctic acid, preferably sodium deoxycholate and thioctic acid in a ratio of 1: 1 to 2. It can be included in weight ratio.
제3상 성분 중 상기 피부흡수 촉진제는 카르니틴(Carnitine)을 포함할 수 있다.Among the third-phase components, the skin absorption accelerator may include carnitine.
또한, 제3상 성분 중 상기 피부유화제는 카프릴릴글라이콜(Caprylyl glycol)을 포함할 수 있으며, 상기 보습제는 부틸렌글라이콜을 포함할 수 있다.In addition, among the third-phase ingredients, the skin emulsifier may include Caprylyl glycol, and the moisturizer may include butylene glycol.
또한, 상기 현탁화제는 하이드로제네이티드레시틴(Hydrogenated Lecithin)을 포함할 수 있고, 상기 유화안정제는 하이드록시프로필사이클로덱스트린(HydroxypropylCyclodextrin)을 포함할 수 있다. In addition, the suspending agent may include Hydrogenated Lecithin, and the emulsion stabilizer may include HydroxypropylCyclodextrin.
그리고, 상기 보존제는 1,2-헥산다이올(1,2-Hexanediol) 및 에틸헥실글리세린(Ethylhexylglycerin) 중에서 선택된 1종 이상을 포함할 수 있고, 바람직하게는 1,2-헥산다이올 및 에틸헥실글리세린을 1 : 0.2 ~ 0.6 중량비로 포함할 수 있다.In addition, the preservative may include at least one selected from 1,2-hexanediol and ethylhexylglycerin, preferably 1,2-hexanediol and ethylhexyl Glycerin may be included in a weight ratio of 1:0.2 to 0.6.
상기 향료는 당업계에서 사용하는 일반적인 향료를 사용할 수 있고, 바람직한 일례를 들면, 시트랄(Citral) 및 리날룰(Linalool)을 포함할 수 있다.As the fragrance, general fragrances used in the art may be used, and preferred examples may include citral and linalool.
다음으로, 본 발명 화장료 제조방법의 6단계는 5단계에서 제조한 제5용해액을 20℃ ~ 30℃, 바람직하게는 25℃ ~ 30℃로 냉각한 후, 탈포 처리한 다음, 냉장 보관할 수 있다.Next, in step 6 of the cosmetic preparation method of the present invention, the fifth lysate prepared in step 5 is cooled to 20 ° C to 30 ° C, preferably 25 ° C to 30 ° C, defoamed, and then stored in a refrigerator. .
이렇게 제조한 본 발명의 화장료는 피부 트러블이 없으면서도, 피부 미백 피부 진정, 피부 항산화, 피부 항상성 유지 및 피부 노화 예방 효과가 우수하면서 피부 보습성 및 기능성 성분의 피부 흡수율이 매우 우수한 바, 이를 다양한 기능성 화장료로 적용하기에 적합하다. The cosmetic of the present invention prepared in this way has excellent effects of skin whitening, skin soothing, skin antioxidant, maintenance of skin homeostasis, and prevention of skin aging without causing skin trouble, and has excellent skin moisturizing properties and skin absorption rate of functional ingredients. It is suitable for application as a cosmetic.
본 발명의 기능성 화장료는 스킨, 에멀젼, 로션 또는 크림 제형의 다양한 화장품의 화장료로 사용할 수 있으며, 고주파기를 이용한 피부 관리시 사용되는 화장품으로서 사용하여 기능성 유효성분의 피부 흡수력을 크게 증대시킬 수 있다.The functional cosmetic of the present invention can be used as a cosmetic for skin, emulsion, lotion or cream formulations of various cosmetics, and can greatly increase the skin absorption of functional active ingredients by using it as a cosmetic used for skin care using a radio frequency machine.
이하, 실시예를 통하여 본 발명을 더욱 구체적으로 설명하기로 하지만, 하기 실시예가 본 발명의 범위를 제한하는 것은 아니며, 이는 본 발명의 이해를 돕기 위한 것으로 해석되어야 할 것이다.Hereinafter, the present invention will be described in more detail through examples, but the following examples are not intended to limit the scope of the present invention, which should be interpreted to aid understanding of the present invention.
[실시예] [Example]
실시예1 : 기능성 화장료의 제조Example 1: Manufacturing of functional cosmetics
(1) 제1상 및 제2상의 제조(1) Preparation of phase 1 and phase 2
알란토인 및 트라넥삼산를 1:20 중량비로 포함하는 피부컨디셔닝제, 글리세린 및 다이프로필렌글라이콜를 1:0.65 중량비로 포함하는 보습제, 다이소듐EDTA(금속이온봉쇄제) 및 정제수를 하기 표 1과 같은 비율로 혼합하여 제1상을 제조하였다.A skin conditioning agent containing allantoin and tranexamic acid in a weight ratio of 1:20, a moisturizer containing glycerin and dipropylene glycol in a weight ratio of 1:0.65, disodium EDTA (metal ion sequestering agent) and purified water in the ratio shown in Table 1 below was mixed to prepare the first phase.
카프릴릭/카프릭트라이글리세라이드, 세틸에틸헥사노에이트 및 에틸헥실팔미테이트를 1:0.3 중량비로 포함하는 피부유연제, 유화제(세테아릴알코올, 솔비탄세스퀴올리에이트, 피이지-100스테아레이트 및 솔비탄스테아레이트), 폴리솔베이트60 및 글리세릴스테아레이트를 1:0.25 중량비로 포함하는 계면활성제, 페트롤라툼(피부흡수 촉진제), 다이메티콘, 마카다미아씨 오일 및 토코페릴아세테이트를 1:0.1:0.2 중량비로 포함하는 피부보호제 및 정제수를 하기 표 1과 같은 비율로 혼합하여 제2상을 제조하였다.Skin softener containing caprylic/capric triglyceride, cetylethylhexanoate and ethylhexyl palmitate in a weight ratio of 1:0.3, emulsifier (cetearyl alcohol, sorbitan sesquioleate, PEG-100 stearate) and sorbitan stearate), a surfactant containing polysorbate 60 and glyceryl stearate in a weight ratio of 1:0.25, petrolatum (skin absorption promoter), dimethicone, macadamia seed oil and tocopheryl acetate in a ratio of 1: A second phase was prepared by mixing a skin protectant and purified water at a weight ratio of 0.1:0.2 in the ratio shown in Table 1 below.
조성Phase 1
Furtherance
조성phase 2
Furtherance
= 1:0.3 중량비Cetylethylhexanoate and Ethylhexylpalmitate
= 1:0.3 weight ratio
(2) 제3상의 제조(2) Preparation of the third phase
진공 저온 열수 추출물 및 에탄올 추출물을 1 : 0.31 중량비로 혼합한 천연식물 기능성 복합 추출물, 부틸렌글라이콜(보습제), 병풀 유래의 아시아티코사이드(피부재생제), 소듐디옥시콜레이트 및 티옥트산을 1:1 중량비로 포함하는 피부탄력개선제, 카르릴릴글라이콜(피부유화제), 카르니틴(피부흡소 촉진제), 하이드로제네이티드레시틴(현탁화제), 하이드록시프로필사이클로덱스트린(유화안정제), 포타슘하이드록사이드(pH 조절제), 시트랄 및 리날룰 1:1 중량비로 포함하는 향료(Fragrance) 및 1,2-헥산다이올 및 에틸헥실글리세린을 1 : 0.2 중량비로 포함하는 보존제를 하기 표 2와 같은 함량으로 혼합하여 제3상을 제조하였다. Natural plant functional complex extract mixed with vacuum low-temperature hot water extract and ethanol extract at a weight ratio of 1: 0.31, butylene glycol (moisturizer), centella asiaticoside (skin regenerator), sodium deoxycholate and thioctic acid : 1 weight ratio of skin elasticity improving agent, carlyl glycol (skin emulsifying agent), carnitine (skin absorption accelerator), hydrogenated lecithin (suspending agent), hydroxypropylcyclodextrin (emulsion stabilizer), potassium hydroxide (pH adjuster), a fragrance containing citral and linalool in a weight ratio of 1: 1, and a preservative containing 1,2-hexanediol and ethylhexylglycerin in a weight ratio of 1: 0.2 in the contents shown in Table 2 below. Mix to prepare a third phase.
이때, 제3상은 고압액상유화기(micro fluidizer)를 이용하여 상기 성분을 균질하게 혼합 및 약 15,000 psi 압력 하에서 미분화시킨 것이다.At this time, in the third phase, the components are homogeneously mixed and pulverized under a pressure of about 15,000 psi using a micro fluidizer.
그리고, 상기 천연식물 기능성 복합 추출물의 진공 저온 열수 추출물은 하기 표 3의 천연식물 각각에 대한 진공 저온 열수 추출물을 하기 표 3의 비율로 혼합한 것이고, 에탄올 추출물은 하기 표 3의 천연식물 각각에 대한 에탄올 추출물을 하기 표 3의 비율로 혼합한 것이다. In addition, the vacuum low-temperature hot-water extract of the natural plant functional complex extract is a mixture of the vacuum low-temperature hot-water extract for each natural plant in Table 3 below in the ratio shown in Table 3, and the ethanol extract is for each natural plant in Table 3 below. The ethanol extract was mixed in the ratio shown in Table 3 below.
추출물
(진공
저온 추물)hydrothermal
extract
(vacuum
cold brew)
(3) 기능성 화장료의 제조(3) Manufacture of functional cosmetics
반응 탱크에 상기 제1상을 넣고, 70℃까지 가온시킨 후, 교반하여 제1용해액을 제조하였다. The first phase was put into a reaction tank, heated to 70° C., and then stirred to prepare a first solution.
다음으로, 상기 제1용해액의 온도를 유지하면서, 제1용해액이 담긴 반응 탱크에 카보머 수용액(카보머 농도 2.5 중량%) 을 투입한 후, 70℃에서 교반속도 1,000 rpm로 10분간 교반하여 제2용해액을 제조하였다. Next, while maintaining the temperature of the first dissolved solution, an aqueous carbomer solution (carbomer concentration of 2.5% by weight) was added to the reaction tank containing the first dissolved solution, and then stirred at 70 ° C. at a stirring speed of 1,000 rpm for 10 minutes Thus, a second solution was prepared.
다음으로, 제2용해액을 80℃까지 가온시킨 후, 상기 제2상을 투입한 다음, 교반속도 600 rpm 로 12분간 수행하여 제3용해액을 제조하였다.Next, after warming the second solution to 80 ° C., the second phase was added, followed by stirring at a speed of 600 rpm for 12 minutes to prepare a third solution.
다음으로, 80℃의 제3용해액에 알지닌 수용액(알지닌 농도 1.64 중량%)을 투입한 후, 교반속도 600 rpm 로 10분간 수행하여 제4용해액을 제조하였다. Next, after adding an arginine aqueous solution (arginine concentration: 1.64% by weight) to the third solution at 80 ° C., a fourth solution was prepared by stirring at a speed of 600 rpm for 10 minutes.
다음으로, 제4용해액을 약 42~43℃로 식힌 후, 상기 제3상을 투입한 다음, 교반속도 700 rpm 조건으로 5분간 교반하여 제5용해액을 제조하였다.Next, after cooling the fourth solution to about 42-43 ° C., the third phase was added, and then stirred for 5 minutes at a stirring speed of 700 rpm to prepare a fifth solution.
다음으로, 제5용해액을 30℃로 냉각한 후, 탈포 처리하여 불투명한 미색의 유액상인 기능성 화장료를 제조하였다.Next, after cooling the fifth solution to 30 ° C., degassing was performed to prepare a functional cosmetic in the form of an opaque off-white emulsion.
기능성 화장료에 사용된 제1상, 카보머 수용액, 제2상, 알지닌 수용액 및 제3상의 사용량(함량)은 하기 표 4와 같다. The amount (content) of the first phase, the carbomer aqueous solution, the second phase, the arginine aqueous solution, and the third phase used in functional cosmetics is shown in Table 4 below.
실시예 2 ~ 3 및 비교예 1 ~ 2 : 기능성 화장료의 제조 Examples 2 to 3 and Comparative Examples 1 to 2: Preparation of functional cosmetics
상기 실시예 1과 동일한 방법으로 기능성 화장료를 제조하되, 하기 표 1과 같은 함량을 가지도록 각 공정마다 조성물을 사용하여 기능성 화장료을 각각 제조하여 실시예 2 ~ 3및 비교예 1 ~ 2를 실시하였다.Functional cosmetics were prepared in the same manner as in Example 1, but Examples 2 to 3 and Comparative Examples 1 to 2 were carried out by preparing functional cosmetics using the composition for each process so as to have the contents shown in Table 1 below.
중량%16.20
weight%
중량%18.33
weight%
중량%14.02
weight%
중량%2.11
weight%
중량%2.05
weight%
중량%63.17
weight%
중량%63.80
weight%
중량%2.80
weight%
실험예 1 : 피부 첩포 실험Experimental Example 1: Skin Patch Experiment
실시예 1에서 제조한 기능성 화장료를 크림 제형의 화장품으로 제조한 후, 이를 O사의 피부임상시험센터에 의뢰하여 피부임상시험을 수행하였다(시험기간 2022.07.18 ~ 2022.07.22). 시험참여피험자는 총 30명(만 20세 ~ 60세의 여성, 평균 연력 45.47세)이었으며, 시험방법은 하기 표 5와 같으며, 자극성 평가 판정 기준 및 피부자극지수계산 공식은 하기 표 6과 같다.After making the functional cosmetic prepared in Example 1 into a cream-type cosmetic, it was commissioned to the skin clinical test center of O company to conduct a skin clinical test (test period 2022.07.18 ~ 2022.07.22). A total of 30 subjects participated in the test (female between the ages of 20 and 60, average age 45.47 years old), and the test method is shown in Table 5 below, and the irritation evaluation criterion and skin irritation index calculation formula are shown in Table 6 below. .
2. 평가 : 피부과 전문의 육안평가
3. 자극 유무 판정 :Frosch&Kligman, CTFA guideline, Draize 방법을 응용하여 판정.1. Area to be patched: After wiping the area without discoloration or skin damage with 70% ethanol on the flat area of the subject's back, excluding the spine, dry it, load 20 μl of the test product, fix it on the skin, and patch it for 24 hours. , evaluations were made 30 minutes and 24 hours after patch removal.
2. Evaluation: Visual evaluation by a dermatologist
3. Determination of stimulation: Determined by applying Frosch&Kligman, CTFA guideline, and Draize method.
[식 1][Equation 1]
피부 첩포 측정 결과, 실시예 1의 기능성 화장료(크림 제형 화장품)는 무자극으로 판정되었다(표 7 참조).As a result of skin patch measurement, the functional cosmetic (cream cosmetic) of Example 1 was determined to be non-irritating (see Table 7).
지수Stimulation
jisoo
평가pepper
evaluation
실험예 2 : 피부탄력 개선효과Experimental Example 2: Skin elasticity improvement effect
실제 사람의 피부에서의 탄력 개선 효과를 시험하기 위하여 상기 실시예 1~3 및 비교예 1~2의 화장료를 크림 제형의 화장품으로 각각 제조한 후, 이를 이용하여 다음과 같이 시험하였다. 30~40대 여성 60명을 각각 15명씩 4조로 나누고 각 조에 실시예 1~3 및 비교예 1~2를 나누어 준 후, 아침 또는 저녁으로 매일1회씩1주간 안면에 도포하게 하였다. In order to test the elasticity improvement effect on actual human skin, the cosmetics of Examples 1 to 3 and Comparative Examples 1 to 2 were prepared as cream-type cosmetics, and then tested as follows. 60 women in their 30s and 40s were divided into 4 groups of 15 each, and Examples 1-3 and Comparative Examples 1-2 were distributed to each group, and then applied to the face once daily in the morning or evening for 1 week.
얼굴에 크림 도포 후, 고주파기를 이용하여 화장료의 피부흡수를 돕게 하였다.After applying the cream to the face, a high frequency machine was used to help skin absorption of cosmetics.
1주 후 피부탄력측정기(Cutometer SEM 575, C+KElectronic Co., Germany)를 이용하여 피부탄력 개선 효과(피부 점탄성, viscoelasticity)를 측정하였으며, 그 결과는 하기 표 8에 나타내었다. 표 8의 대조군은 크림을 사용하지 않은 경우이고, 이를 기준으로 피부 탄력 개선 효과를 구하여 표현한 것이다.After 1 week, the skin elasticity improvement effect (skin viscoelasticity) was measured using a skin elasticity measuring device (Cutometer SEM 575, C+KElectronic Co., Germany), and the results are shown in Table 8 below. The control group in Table 8 is the case where no cream was used, and the skin elasticity improvement effect was obtained and expressed based on this.
상기 표 8을 살펴보면, 비교예 1의 경우, 피부탄력 증대 효과가 실시예 1 ~ 3 및 비교예 2 보다 떨어지는 결과를 보였다. 이에 반해 실시예 1 ~ 3 및 비교예 2는 높은 피부탄력 증대 효과를 보였다.Looking at Table 8, in the case of Comparative Example 1, the effect of increasing skin elasticity was lower than that of Examples 1 to 3 and Comparative Example 2. In contrast, Examples 1 to 3 and Comparative Example 2 showed a high effect of increasing skin elasticity.
실험예3 : 피부보습 및 보습 지속력 평가Experimental Example 3: Evaluation of skin moisturizing and moisturizing durability
상기 크림에 대한 임상보습효과 및 지속력을 다음과 같이 측정하였다. The clinical moisturizing effect and durability of the cream were measured as follows.
설문조사를 통하여 피부가 건조하다고 느끼는 건강한 성인남녀 30 명의 상박팔뚝에 상기 실시예 1 ~ 3및 비교예 1 ~ 2의 화장료를 크림 제형의 화장품으로 각각 제조한 후, 각 크림을 각각 1일 2회씩1주간 도포하도록 하였다. Through a survey, the cosmetics of Examples 1 to 3 and Comparative Examples 1 to 2 were prepared as cream-type cosmetics on the forearms of 30 healthy adult men and women who felt their skin was dry, and then each cream was applied twice a day. It was applied for 1 week.
실험예 2와 동일하게 얼굴에 크림 도포 후, 고주파기를 이용하여 화장료의 피부흡수를 돕게 하였다.After applying the cream to the face in the same manner as in Experimental Example 2, a radiofrequency machine was used to help skin absorption of cosmetics.
보습 효과는 실사용시험 시작 후부터 종료 후의 개선효과를Corneometer CM 820 (Corage+Khazaka,Germany)를 이용하여 표피수분량에 따른 피부 전기전도도의 증가율(%)을 수치화하여 평가하였다. 실험 결과는 하기 표 9에 나타내었다.The moisturizing effect was evaluated by digitizing the increase rate (%) of skin electrical conductivity according to the amount of epidermal moisture using Corneometer CM 820 (Corage+Khazaka, Germany) to improve the effect from the start to the end of the actual use test. The experimental results are shown in Table 9 below.
상기 표 9의 실험결과를 살펴보면, 제1상을 15 중량% 미만으로 사용한 비교예 1및 제2상을 60 중량% 미만으로 사용한 비교예 2의 경우, 실시예 1 ~ 3 에 비해 보습성이 떨어지는 결과를 보였다. 이에 반해 실시예 1 ~ 3 은 15% 이상의 피부 전기전도도 증가율을 보여 우수한 보습성 및 보습 지속력을 보였다.Looking at the experimental results of Table 9, in the case of Comparative Example 1 using less than 15% by weight of the first phase and Comparative Example 2 using less than 60% by weight of the second phase, the moisturizing properties were inferior to those of Examples 1 to 3. showed results. On the other hand, Examples 1 to 3 showed an increase in skin electrical conductivity of 15% or more, showing excellent moisturizing properties and moisturizing durability.
상기 실시예 및 실험예를 통하여 본 발명의 기능성 화장료 및 이를 이용하여 제조한 화장품이 인체에 무해하고 피부 트러블이 없으면서, 피부 보습성 및 피부 진정 효과 및 피부 탄력 개선 효과가 있음을 확인할 수 있었다. 이러한 본 발명의 기능성 화장료는 다양한 기능성 화장품에 적용할 수 있으며, 바람직한 일례를 들면 로션 제형의 화장품으로서 고주파기를 이용한 피부관리시 사용되는 화장품으로서 사용하여 기능성 유효성분의 피부 흡수력을 증대시킬 수 있으며, 얼굴 지방 분해 및 축소를 위한 쉐이빙 기법에 따른 피부 관리시 적용하기 적합하다.Through the above examples and experimental examples, it was confirmed that the functional cosmetics of the present invention and cosmetics manufactured using the same are harmless to the human body and have no skin troubles, and have skin moisturizing properties, skin soothing effects, and skin elasticity improvement effects. The functional cosmetic of the present invention can be applied to various functional cosmetics, and a preferred example is a lotion-type cosmetic that can be used as a cosmetic used in skin care using a radio frequency machine to increase the skin absorption of functional active ingredients, It is suitable for skin care according to shaving technique for fat decomposition and reduction.
Claims (10)
제1용해액에 유화안정제를 혼합 및 분산시켜서 제2용해액을 제조하는 2단계;
제2용해액에 제2상을 투입한 후, 가온 및 교반하여 제3용해액을 제조하는 3단계;
상기 제3용해액에 알지닌(Arginine) 수용액을 혼합하여 제4용해액을 제조하는 4단계;
상기 제4용해액에 제3상을 투입한 후, 교반을 수행하여 제5용해액을 제조하는 5단계; 및
제5용해액을 냉각, 탈포처리 및 보관하는 6단계;를 포함하는 공정을 수행하며,
상기 제5용해액은 상기 제1상 16.5 ~ 17.5 중량%, 상기 유화안정제 1.80 ~ 2.25 중량%, 상기 제2상 62.00 ~ 64.00 중량%, 알지닌 수용액 2.70 ~ 3.10 중량% 및 100 중량% 중 나머지 잔량의 제3상을 포함하고,
상기 제1상은 정제수 100 중량부에 대하여, 피부컨디셔닝제 15 ~ 35 중량부, 보습제 80 ~ 130 중량부, 금속이온봉쇄제 1 ~ 5 중량부를 포함하며,
제1상의 상기 피부컨디셔닝제는 알란토인 및 트라넥삼산을 1 : 10 ~ 30 중량비로 포함하고,
제1상의 상기 보습제는 글리세린 및 다이프로필렌글라이콜을 1 : 0.5 ~1.0 중량비로 포함하며,
상기 유화안정제는 카보머 2.0 ~ 5.0 중량% 및 나머지 잔량의 물을 포함하는 카보머 수용액을 포함하고,
상기 제2상은 카프릴릭/카프릭트라이글리세라이드, 피부유연제, 유화제, 계면활성제, 피부흡수 촉진제, 피부보호제 및 물을 포함하고,
상기 제3상은 열수 추출물 및 알코올 추출물을 1 : 0.2 ~ 0.5 중량비로 포함하는 천연식물 유래 기능성 복합추출물; 피부재생제; 피부탄력개선제; 피부흡수 촉진제; 피부유화제; 부틸렌글리콜을 포함하는 보습제; 현탁화제; 유화안정제; pH 조절제; 보존제; 및 향료;를 포함하며,
상기 열수 추출물은 라벤더꽃추출물 100 중량부에 대하여, 클레리추출물(Salvia Sclarea Extract) 50 ~ 150 중량부, 히아신스전초추출물(Hyacinthus Orientalis Extract) 50 ~ 120 중량부, 보리지추출물(Borago Officinalis Extract) 70 ~ 130 중량부, 귤추출물(Citrus Unshiu Fruit Extract) 50 ~ 150 중량부, 유자추출물(Citrus Junos Fruit Extract) 50 ~ 150 중량부, 녹차잎추출물 70 ~ 120 중량부, 포트마리골드꽃추출물(Calendula Officinalis Flower Extract) 50 ~ 120 중량부, 로즈마리추출물(Rosemary Extract) 70 ~ 120 중량부, 당느릅나무껍질추출물(UlmusCampestris Bark Extract) 50 ~ 150 중량부, 민들레전초추출물(TaraxacumPlatycarpum Extract) 80 ~ 130 중량부, 개똥쑥추출물(Artemisia Annua Extract) 70 ~ 120 중량부 및 쇠비름추출물(PortulacaOleracea Extract) 50 ~ 110 중량부를 포함하고,
상기 알코올 추출물은 수레국화꽃추출물(CentaureaCyanus Flower Extract) 100 중량부에 대하여, 유채꽃추출물(Brassica Campestris Flower Extract) 50 ~ 150 중량부, 마트리카리아꽃추출물(ChamomillaRecutita Flower Extract) 70 ~ 120 중량부, 흰목이버섯추출물(TremellaFuciformis Extract) 50 ~ 150 중량부 및 스타아니스추출물(IlliciumVerum Fruit Extract) 90 ~ 150 중량부를 포함하는 것을 특징으로 하는 피부탄력을 위한 조성 및 조성비를 가지는 기능성 화장료의 제조방법.
A first step of dissolving the first phase by putting the first phase in a reactor, heating and stirring to prepare a first solution;
a second step of preparing a second solution by mixing and dispersing an emulsion stabilizer in the first solution;
Step 3 of preparing a third solution by heating and stirring after adding the second phase to the second solution;
a fourth step of preparing a fourth solution by mixing an aqueous solution of arginine with the third solution;
Step 5 of preparing a fifth solution by adding a third phase to the fourth solution and then performing stirring; and
Step 6 of cooling, defoaming, and storing the fifth lysate; performing a process including;
The fifth solution is the remainder of 16.5 to 17.5% by weight of the first phase, 1.80 to 2.25% by weight of the emulsion stabilizer, 62.00 to 64.00% by weight of the second phase, 2.70 to 3.10% by weight of the arginine aqueous solution and 100% by weight. Including the third phase of
The first phase includes 15 to 35 parts by weight of a skin conditioning agent, 80 to 130 parts by weight of a moisturizer, and 1 to 5 parts by weight of a sequestering agent, based on 100 parts by weight of purified water,
The skin conditioning agent of the first phase includes allantoin and tranexamic acid in a weight ratio of 1:10 to 30,
The moisturizer of the first phase includes glycerin and dipropylene glycol in a weight ratio of 1:0.5 to 1.0,
The emulsion stabilizer includes an aqueous carbomer solution containing 2.0 to 5.0% by weight of carbomer and the remaining amount of water,
The second phase includes caprylic/capric triglyceride, a skin softener, an emulsifier, a surfactant, a skin absorption accelerator, a skin protectant, and water,
The third phase is a natural plant-derived functional complex extract containing a hot water extract and an alcohol extract in a weight ratio of 1: 0.2 to 0.5; skin regeneration agent; skin elasticity improving agent; skin absorption accelerator; skin emulsifier; Moisturizer containing butylene glycol; suspending agents; emulsion stabilizer; pH adjusting agent; preservatives; And fragrance; including,
The hot water extract is based on 100 parts by weight of lavender flower extract, 50 to 150 parts by weight of Salvia Scalarea Extract, 50 to 120 parts by weight of Hyacinthus Orientalis Extract, 70 parts by weight of Borago Officinalis Extract ~ 130 parts by weight, Citrus Unshiu Fruit Extract 50 ~ 150 parts by weight, Citrus Junos Fruit Extract 50 ~ 150 parts by weight, Green tea leaf extract 70 ~ 120 parts by weight, Port Marigold flower extract (Calendula Officinalis Flower Extract 50 ~ 120 parts by weight, Rosemary Extract 70 ~ 120 parts by weight, Ulmus Campestris Bark Extract 50 ~ 150 parts by weight, Taraxacum Platycarpum Extract 80 ~ 130 parts by weight, 70 to 120 parts by weight of Artemisia Annua Extract and 50 to 110 parts by weight of PortulacaOleracea Extract,
The alcohol extract is based on 100 parts by weight of Centaurea Cyanus Flower Extract, 50 to 150 parts by weight of Brassica Campestris Flower Extract, 70 to 120 parts by weight of Chamomilla Recutita Flower Extract, A method for producing a functional cosmetic having a composition and composition ratio for skin elasticity, comprising 50 to 150 parts by weight of Tremella Fuciformis Extract and 90 to 150 parts by weight of IlliciumVerum Fruit Extract.
상기 유화제는 세테아릴알코올(Cetearyl Alcohol), 솔비탄세스퀴올리에이트(SorbitanSesquioleate), 피이지-100스테아레이트(PEG-100 Stearate) 및 솔비탄스테아레이트(Sorbitan Stearate) 중에서 선택된 1종 이상을 포함하며,
상기 계면활성제는 폴리솔베이트60(Polysorbate 60) 및 글리세릴스테아레이트(Glyceryl Stearate) 중에서 선택된 1종 이상을 포함하고,
상기 피부보호제는 다이메티콘(Dimethicone), 마카다미아씨 오일(Macadamia Ternifolia Seed Oil) 및 토코페릴아세테이트(Tocopheryl Acetate) 중에서 선택된 1종 이상을 포함하는 것을 특징으로 하는 피부탄력을 위한 조성 및 조성비를 가지는 기능성 화장료의 제조방법.
The method of claim 1, wherein the skin softener includes at least one selected from CetylEthylhexanoate and Ethylhexyl Palmitate,
The emulsifier includes at least one selected from Cetearyl Alcohol, Sorbitan Sesquioleate, PEG-100 Stearate and Sorbitan Stearate. and
The surfactant includes at least one selected from polysorbate 60 and glyceryl stearate,
The skin protectant is functional having a composition and composition ratio for skin elasticity, characterized in that it comprises at least one selected from dimethicone, macadamia seed oil (Macadamia Ternifolia Seed Oil) and tocopheryl acetate (Tocopheryl Acetate) Manufacturing method of cosmetics.
The method of claim 1, wherein the aqueous solution of arginine in step 4 contains 1.0 to 5.0% by weight of arginine and the remaining amount of water.
상기 피부재생제는 아시아티코사이드를 포함하며,
상기 피부탄력개선제는 소듐디옥시콜레이트(Sodium Deoxycholate) 및 티옥트산(Thioctic Acid) 중에서 선택된 1종 이상을 포함하고,
상기 피부흡수 촉진제는 카르니틴(Carnitine)을 포함하며,
상기 피부유화제는 카프릴릴글라이콜(Caprylyl glycol)을 포함하고,
상기 현탁화제는 하이드로제네이티드레시틴(Hydrogenated Lecithin)을 포함하고,
제3상의 상기 유화안정제는 하이드록시프로필사이클로덱스트린(HydroxypropylCyclodextrin)을 포함하며,
상기 보존제는 1,2-헥산다이올(1,2-Hexanediol) 및 에틸헥실글리세린(Ethylhexylglycerin) 중에서 선택된 1종 이상을 포함하고,
상기 향료는 시트랄(Citral) 및 리날룰(Linalool)을 포함하는 것을 특징으로 하는 피부탄력을 위한 조성 및 조성비를 가지는 기능성 화장료의 제조방법.
According to claim 1,
The skin regeneration agent includes asiaticoside,
The skin elasticity improving agent includes at least one selected from sodium deoxycholate and thioctic acid,
The skin absorption accelerator includes carnitine,
The skin emulsifier includes caprylyl glycol (Caprylyl glycol),
The suspending agent includes Hydrogenated Lecithin,
The emulsion stabilizer of the third phase includes hydroxypropylcyclodextrin,
The preservative includes at least one selected from 1,2-hexanediol and ethylhexylglycerin,
The fragrance is a method for producing a functional cosmetic having a composition and composition ratio for skin elasticity, characterized in that it includes citral and linalool.
상기 용해액은 상기 제1상 16.5 ~ 17.5 중량%, 상기 유화안정제 1.80 ~ 2.25 중량%, 상기 제2상 62.00 ~ 64.00 중량%, 알지닌 수용액 2.70 ~ 3.10 중량% 및 100 중량% 중 나머지 잔량의 제3상을 포함하고,
제1상의 상기 피부컨디셔닝제는 알란토인 및 트라넥삼산을 1 : 10 ~ 30 중량비로 포함하고,
제1상의 상기 보습제는 글리세린 및 다이프로필렌글라이콜을 1 : 0.5 ~ 1.0 중량비로 포함하며,
상기 제3상은 열수 추출물 및 알코올 추출물을 1 : 0.2 ~ 0.5 중량비로 포함하는 천연식물 유래 기능성 복합추출물; 피부재생제; 피부탄력개선제; 피부흡수 촉진제; 피부유화제; 부틸렌글리콜을 포함하는 보습제; 현탁화제; 유화안정제; pH 조절제; 보존제; 및 향료;를 포함하며,
상기 열수 추출물은 라벤더꽃추출물 100 중량부에 대하여, 클레리추출물(Salvia Sclarea Extract) 50 ~ 150 중량부, 히아신스전초추출물(Hyacinthus Orientalis Extract) 50 ~ 120 중량부, 보리지추출물(Borago Officinalis Extract) 70 ~ 130 중량부, 귤추출물(Citrus Unshiu Fruit Extract) 50 ~ 150 중량부, 유자추출물(Citrus Junos Fruit Extract) 50 ~ 150 중량부, 녹차잎추출물 70 ~ 120 중량부, 포트마리골드꽃추출물(Calendula Officinalis Flower Extract) 50 ~ 120 중량부, 로즈마리추출물(Rosemary Extract) 70 ~ 120 중량부, 당느릅나무껍질추출물(UlmusCampestris Bark Extract) 50 ~ 150 중량부, 민들레전초추출물(TaraxacumPlatycarpum Extract) 80 ~ 130 중량부, 개똥쑥추출물(Artemisia Annua Extract) 70 ~ 120 중량부 및 쇠비름추출물(PortulacaOleracea Extract) 50 ~ 110 중량부를 포함하고,
상기 알코올 추출물은 수레국화꽃추출물(CentaureaCyanus Flower Extract) 100 중량부에 대하여, 유채꽃추출물(Brassica Campestris Flower Extract) 50 ~ 150 중량부, 마트리카리아꽃추출물(ChamomillaRecutita Flower Extract) 70 ~ 120 중량부, 흰목이버섯추출물(TremellaFuciformis Extract) 50 ~ 150 중량부 및 스타아니스추출물(IlliciumVerum Fruit Extract) 90 ~ 150 중량부를 포함하는 것을 특징으로 하는 피부탄력을 위한 조성 및 조성비를 가지는 기능성 화장료.
A first phase containing 15 to 35 parts by weight of a skin conditioning agent, 80 to 130 parts by weight of a moisturizer, and 1 to 5 parts by weight of a sequestering agent based on 100 parts by weight of purified water; An emulsion stabilizer containing an aqueous carbomer solution containing 2.0 to 5.0% by weight of carbomer and the remaining amount of water; a second phase containing caprylic/capric triglyceride, a skin softener, an emulsifier, a surfactant, a skin absorption accelerator, a skin protectant, and water; Arginine aqueous solution; And a third phase; including a solution obtained by mixing and dissolving in turn,
The dissolved solution is the remaining balance of 16.5 to 17.5% by weight of the first phase, 1.80 to 2.25% by weight of the emulsion stabilizer, 62.00 to 64.00% by weight of the second phase, 2.70 to 3.10% by weight of the arginine aqueous solution and 100% by weight. including three phases,
The skin conditioning agent of the first phase contains allantoin and tranexamic acid in a weight ratio of 1:10 to 30,
The moisturizer of the first phase includes glycerin and dipropylene glycol in a weight ratio of 1: 0.5 to 1.0,
The third phase is a natural plant-derived functional complex extract containing a hot water extract and an alcohol extract in a weight ratio of 1: 0.2 to 0.5; skin regeneration agent; skin elasticity improving agent; skin absorption accelerator; skin emulsifier; Moisturizer containing butylene glycol; suspending agents; emulsion stabilizer; pH adjusting agent; preservatives; And fragrance; including,
The hot water extract is based on 100 parts by weight of lavender flower extract, 50 to 150 parts by weight of Salvia Scalarea Extract, 50 to 120 parts by weight of Hyacinthus Orientalis Extract, 70 parts by weight of Borago Officinalis Extract ~ 130 parts by weight, Citrus Unshiu Fruit Extract 50 ~ 150 parts by weight, Citrus Junos Fruit Extract 50 ~ 150 parts by weight, Green tea leaf extract 70 ~ 120 parts by weight, Port Marigold flower extract (Calendula Officinalis Flower Extract 50 ~ 120 parts by weight, Rosemary Extract 70 ~ 120 parts by weight, Ulmus Campestris Bark Extract 50 ~ 150 parts by weight, Taraxacum Platycarpum Extract 80 ~ 130 parts by weight, 70 to 120 parts by weight of Artemisia Annua Extract and 50 to 110 parts by weight of PortulacaOleracea Extract,
The alcohol extract is based on 100 parts by weight of Centaurea Cyanus Flower Extract, 50 to 150 parts by weight of Brassica Campestris Flower Extract, 70 to 120 parts by weight of Chamomilla Recutita Flower Extract, A functional cosmetic having a composition and composition ratio for skin elasticity, comprising 50 to 150 parts by weight of Tremella Fuciformis Extract and 90 to 150 parts by weight of IlliciumVerum Fruit Extract.
Cosmetics for skin care using a cream-type radio frequency machine containing the functional cosmetic of claim 9.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020220130769A KR102513929B1 (en) | 2022-10-12 | 2022-10-12 | Functional comsmetics materials having composition and composition ratio for skin elasticity, Manufacturing method thereof and Comsmetics for skin care |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020220130769A KR102513929B1 (en) | 2022-10-12 | 2022-10-12 | Functional comsmetics materials having composition and composition ratio for skin elasticity, Manufacturing method thereof and Comsmetics for skin care |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR102513929B1 true KR102513929B1 (en) | 2023-03-27 |
Family
ID=85799762
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020220130769A KR102513929B1 (en) | 2022-10-12 | 2022-10-12 | Functional comsmetics materials having composition and composition ratio for skin elasticity, Manufacturing method thereof and Comsmetics for skin care |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR102513929B1 (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101482507B1 (en) | 2014-04-11 | 2015-01-14 | (주)씨아이티 | composition for cosmetics and method of manufacturing the same |
| KR20210053638A (en) * | 2019-11-04 | 2021-05-12 | 아이큐어 주식회사 | cosmetic composition for improving skin condition and manufacturing method thereof |
| KR20220112636A (en) | 2021-02-04 | 2022-08-11 | (주)리윤바이오 | Cosmetic composition helping in improving water content in corneous lower layer comprising the extract of natural products |
-
2022
- 2022-10-12 KR KR1020220130769A patent/KR102513929B1/en active IP Right Grant
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101482507B1 (en) | 2014-04-11 | 2015-01-14 | (주)씨아이티 | composition for cosmetics and method of manufacturing the same |
| KR20210053638A (en) * | 2019-11-04 | 2021-05-12 | 아이큐어 주식회사 | cosmetic composition for improving skin condition and manufacturing method thereof |
| KR20220112636A (en) | 2021-02-04 | 2022-08-11 | (주)리윤바이오 | Cosmetic composition helping in improving water content in corneous lower layer comprising the extract of natural products |
Non-Patent Citations (1)
| Title |
|---|
| 식품의약안정청 "화장품 전성분표시제 설명자료", 2008.08. 1부.* * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8101214B2 (en) | Composition for skin external application containing complex of herbal extracts | |
| EA025223B1 (en) | Topical skin care formulation and method of increasing integrity of dermal-epidermal junction in skin tissues | |
| CN105496938B (en) | α-bisabolol shin moisturizer | |
| KR102227355B1 (en) | Complex cosmetic composition for non-irritating weak acid exfoliation and epithelial cell nutrition | |
| US20100173027A1 (en) | O/w emulsion for hand care | |
| KR102142311B1 (en) | Skin external composition comprising tangeretin | |
| KR102236253B1 (en) | Cosmetic composition for skin improvement comprising extracts derived from natural products and method for manufacturing the same | |
| CN110787088A (en) | Basic composition for lip wrinkle fading and preparation method and application thereof | |
| KR102015173B1 (en) | Low irritating cosmetic composition for skin whitening | |
| KR20160131387A (en) | Composition for skin care | |
| JP3908126B2 (en) | Epidermal keratinization normalizing agent and skin external preparation containing the same | |
| KR20040043192A (en) | Substances capable of potentiating laminin 5 productivity in epidermal cells and utilization thereof | |
| KR102217663B1 (en) | Cosmetic Composition For Skin Moisturizing Containing Mixture of Malva Sylvestris (Mallow) Extract, Aloe Barbadensis Leaf Extract, Dioscorea Japonica Root Extract And Hibiscus Esculentus Fruit Extract | |
| JP2010241762A (en) | Cosmetic | |
| JP5329830B2 (en) | SCF secretion inhibitor and sebum secretion inhibitor | |
| JP3991164B2 (en) | Cosmetic composition comprising jujube extract and walnut extract | |
| JP3370289B2 (en) | Cosmetic and method for producing cosmetic | |
| CN112294739A (en) | Multi-effect whitening composition and application thereof in moisturizer | |
| KR20120057020A (en) | Cosmetic composition for moisturizing or improving skin elasticity | |
| KR20110078955A (en) | Cosmetic composition comprising moisture quality component as active ingredient | |
| KR101155807B1 (en) | Cosmetic composition for moisturizing and firming the skin | |
| JP2004131401A (en) | Skin cosmetic | |
| KR102027647B1 (en) | Low irritating cosmetic composition for skin whitening comprising albutin | |
| KR102513929B1 (en) | Functional comsmetics materials having composition and composition ratio for skin elasticity, Manufacturing method thereof and Comsmetics for skin care | |
| CN116583264A (en) | Cosmetic composition comprising sucrose ester and solvent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| E701 | Decision to grant or registration of patent right | ||
| GRNT | Written decision to grant |